ReviewDiscover oncology2026
Non-coding RNA regulation of the radiation-induced DNA damage response and its translational relevance.
Review in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiotherapy outcomes are strongly influenced by the DNA damage response (DDR), a coordinated network of signalling proteins, that detects breaks in DNA, and governs DNA repair, cell cycle checkpoint activation and cell-fate decisions. While canonical DDR control has traditionally been attributed to protein kinases such as ataxia-telangiectasia mutated (ATM), ATM and rad3-related (ATR), and DNA-dependent protein kinase catalytic subunit (DNA-PKcs), accumulating evidence demonstrates that non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and emerging small RNA classes, serve as important upstream regulators of these pathways. In this review, we synthesise current evidence on how ncRNAs regulate core DDR signalling networks and direct the balance between homologous recombination (HR) and non-homologous end joining (NHEJ), thereby influencing repair fidelity and overall cellular responses to radiation. We outline how ncRNAs regulate early DDR events in response to ionizing radiation, including the sensing of DNA double-strand breaks and the chromatin remodelling required for efficient recruitment of repair factors. In addition, we summarise emerging radiation-responsive RNA species such as DNA damage response RNAs (DDRNAs), vault RNAs (vtRNAs), and tRNA-derived fragments (tRFs) that contribute to genome stability and stress adaptation. Clinically, circulating ncRNAs represent minimally invasive biomarkers of radiation response, and their targeted modulation offers an opportunity for improving radiotherapy outcome, highlighting the translational relevance of defining ncRNA-mediated DDR regulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.